蛋白质生物合成的第四步：翻译终止后复合物的解体

蛋白质合成过程一般被归纳为由合成的起始、肽链的延伸和合成的终止组成的三步曲 . 然而,随着对核糖体再循环因子 (ribosome recycling factor , RRF) 在蛋白质合成过程中作用的深入研究,人们提出了蛋白质生物合成应是四步曲, 这第四步就是翻译终止后核糖体复合物的解体 , 也就是通常说的核糖体循环再利用 . 简要地介绍了翻译终止后复合物解体的可能机制：核糖体再循环因子和蛋白质合成延伸因子 G 在核糖体上协同作用催化这一过程的完成 .     

真核翻译因子与蛋白质生物合成

真核mRNA在80S核糖体上翻译成蛋白质是一个复杂的过程,需要多步反应及多种因子参与,文章就真核蛋白质的生物合成机制简要综述翻译起始、延伸和终止因子的结构、功能和性质及其在肽链合成过程中的作用研究新进展.     

人mRNA输出因子Gle1与肽链释放因子相互作用上调HeLa细胞中蛋白质翻译终止活性

Gle1蛋白是一种mRNA核输出因子. 最近有研究报道Gle1蛋白参与了酿酒酵母的蛋白质翻译终止过程. 为了探讨Gle1蛋白是否在其它生物中也具有同样的功能, 本研究利用酵母双杂交、免疫共沉淀以及免疫共定位等方法证实了人Gle1蛋白与参与蛋白质合成终止的两类肽链释放因子均能够相互作用, 提示hGle1蛋白可能在人细胞中参与了蛋白质的翻译终止过程. 进一步在HeLa细胞中利用双荧光素酶报告系统分析人Gle1蛋白对蛋白质翻译终止的影响,结果显示, hGle1的过表达能促进细胞内蛋白质的翻译终止. 为进一步探讨hGle1蛋白在蛋白质合成中的作用机制奠定了基础.     

真核生物mRNA应激状态下的帽-非依赖性翻译

在真核生物中,mRNA翻译过程包括起始、延伸和终止。其中,翻译的起始阶段最为重要且复杂,它决定了mRNA能否被有效翻译成蛋白质。根据翻译起始机制的不同,真核生物mRNA翻译可以分为传统的帽-依赖性翻译和替代机制帽-非依赖性翻译。当外部环境的刺激或细胞自身的改变使细胞处于应激状态时,传统的帽-依赖性翻译被抑制或下调,替代机制帽-非依赖性翻译得以启动,以保证翻译的顺利进行。真核生物在应激状态下为了维持蛋白质合成的需求,采用多种翻译起始机制来实现帽-非依赖性翻译。其中较常见的是IRES(internal ribosome entry site)、m⁶A修饰和CITE(cap-independent translation enhancer)所启动的翻译。这些机制允许核糖体在mRNA的特殊区域内部进行启动,而不依赖于传统的m⁷G帽结构。通过这些机制,真核生物可以在应激状态下仍然进行蛋白质合成,以满足细胞的需要。本文在总结传统帽-依赖性翻译研究进展基础上,着重介绍IRES、m⁶A和CITE所启动的帽-非依赖性翻译,为更好地探索细胞...     

氨酰-tRNA合成酶维持翻译忠实性的机制

氨酰-tRNA合成酶在维持蛋白质合成忠实性方面具有重要的作用.其忠实性机制可以分为正确地选择底物、转位前编辑、顺式转位后编辑和反式转位后编辑4个水平.不同的氨酰-tRNA合成酶能够利用其中的一种或几种机制,将氨基酸和tRNA连接起来,形成正确的氨酰-tRNA.目前,氨酰-tRNA合成酶的研究超出蛋白质合成,已经延伸到了...     

病毒非经典途径合成蛋白质的分子机制

病毒增殖过程涉及到病毒与宿主蛋白之间复杂的相互作用。为充分利用病毒基因组的有限资源,使病毒基因组编码的蛋白质数量最大化,除经典途径之外,病毒还可通过非经典途径来合成蛋白质。现就非经典途径中,对病毒蛋白质合成的起始、延伸以及终止过程的类型及特征进行综述,为深入研究病毒蛋白质合成的分子机制及抗病毒分子靶标的开发提供参考。     

真核翻译起始因子5A在蛋白质合成中的功能及机制

在蛋白质合成过程中,除核糖体、氨酰 tRNA和mRNA外,还有多种翻译因子参与其中。真核翻译起始因子5A（eukaryotic translation initiation factor 5A, eIF5A）是维持细胞活性必不可少的翻译因子,在进化上高度保守。eIF5A是真核细胞中唯一含有羟腐胺赖氨酸（hypusine）的蛋白质,该翻译后修饰对eIF5A的活性至关重要。1978年,人们首次鉴定出eIF5A,认为它在翻译起始阶段促进第1个肽键的形成。直到2013年才证实它主要在翻译延伸阶段调控含多聚脯氨酸基序蛋白质的翻译。在经过四十多年研究后,人们对eIF5A的功能有了新的认识。近期基于核糖体图谱数据的分析表明,eIF5A能够缓解翻译延伸过程中核糖体在多种基序处的停滞,并不局限于多聚脯氨酸基序,并且它还能够通过促进肽链的释放增强翻译终止。此外,eIF5A还可以通过调控某些蛋白质的翻译,间接影响细胞内的各种生命活动。本文综述了eIF5A的多种翻译后修饰、在蛋白质合成和细胞自噬过程中的调控作用以及与人类疾病的关系,并与细菌及古细菌中的同源蛋白质进行了比较,探讨了该因子在进化中的保守性,以期为相关领域的研究提供一定的理论基础。     

哺乳动物线粒体蛋白质翻译及其调控机制

线粒体是真核细胞内参与能量生成和物质代谢的重要细胞器。线粒体核糖体(mitochondrial ribosome, MR)作为细胞器中的翻译机器,用于表达线粒体DNA(mitochondrial DNA, mtDNA)编码的基因。近年来,随着研究的不断深入,人们对参与哺乳动物线粒体蛋白质翻译的蛋白质因子及其翻译的基本过程有了越来越清晰的认识,这对阐明线粒体蛋白质翻译的调控机制及研究人类线粒体疾病等方面具有重要的意义。线粒体蛋白质的翻译过程分为起始、延伸、终止和回收四个阶段。本文综述哺乳动物线粒体核糖体的结构与功能,以及线粒体蛋白质翻译因子的性质与功能,并进一步探讨翻译激活因子、微小RNA、线粒体COX翻译调控组装中间体(mt-translation regulation assembly intermediate of COX, MITRAC)以及核糖体的翻译后修饰对线粒体蛋白质翻译的调控及其机制,展望其对人类线粒体相关疾病研究的应用前景。     

真核生物mRNA翻译起始机制研究进展

在真核生物中,mRNA翻译是一个复杂的多步骤过程,包括起始、延伸和终止3个阶段。其中,起始阶段的调控是影响mRNA翻译的关键。目前已经发现,mRNA翻译起始方式有多种,以最早发现的m ⁷G帽依赖性扫描机制最为经典,但当细胞处于逆境,经典起始机制受到抑制时,其他类型的起始机制会将其替代以保证翻译的顺利进行。本文对目前已发现的真核生物mRNA不同翻译起始机制特别是经典起始机制的替代机制进行了综述,旨在为深入认识真核生物基因在翻译水平上的表达调控提供参考。     

RNA聚合酶维持转录忠实性的机制

RNA聚合酶(RNAP)在维持转录忠实性方面具有重要的作用,其忠实性机制可以分为特异性的底物选择和校对2种.RNAP高水平的底物选择忠实性主要基于碱基配对和诱导契合机制,而校对功能则通过焦磷酸解和RNAP内在的RNA剪切活性完成.现在,RNAP的研究已经超出了其在转录中的作用,延伸到了其他领域.本文主要论述了RNAP忠实性机制的研究进展,并将之与DNA聚合酶、氨酰-tRNA合成酶及核糖体的忠实性机制进行了比较.最后,论述了RNAP在新药或新药靶点开发中的作用,并对其应用前景进行了展望.     

Expression of an anti apoptotic recombinant short peptide in mammalian cells

Understanding the mechanisms of the apoptotic and anti apoptotic processes may lead to a better way to control these cascades. Here we demonstrated for the first time the feasibility to express a short functional peptide in mammalian cells that abrogates the apoptosis cascade through interference with the proteolytic activity of the initiator caspase 9 and the executing caspase 3 enzymes. The expression of a short peptide that includes the pseudo-substrate motif of the apoptosis inhibitor protein P35 (Asp-Gln-Met-Asp) leads to the abrogation of cell death induced through either the mitochondrial or the death receptors pathways.Short open reading frames have been detected in several mammalian mRNAs, primarily upstream of the main long reading frame (uORFs), however, direct evidence for de-novo peptides translation has not been provided. Utilizing biochemical and imaging techniques we demonstrate here that the functional recombinant peptide was localized to the cytpoplasmic fraction of the cell.In conclusion, this work demonstrates that ribosomes recognize short ORFs to translate stable short recombinant peptides in mammalian cells. Expression of these intracellular peptides results in the knock down of apoptotic processes to generate apoptosis resistant stable cells.     

Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation

Viruses are known to employ different strategies to manipulate the major histocompatibility (MHC) class I antigen presentation pathway to avoid recognition of the infected host cell by the immune system. However, viral control of antigen presentation via the processes that supply and select antigenic peptide precursors is yet relatively unknown. The Epstein-Barr virus (EBV)-encoded EBNA1 is expressed in all EBV-infected cells, but the immune system fails to detect and destroy EBV-carrying host cells. This immune evasion has been attributed to the capacity of a Gly-Ala repeat (GAr) within EBNA1 to inhibit MHC class I restricted antigen presentation. Here we demonstrate that suppression of mRNA translation initiation by the GAr in cis is sufficient and necessary to prevent presentation of antigenic peptides from mRNAs to which it is fused. Furthermore, we demonstrate a direct correlation between the rate of translation initiation and MHC class I antigen presentation from a certain mRNA. These results support the idea that mRNAs, and not the encoded full length proteins, are used for MHC class I restricted immune surveillance. This offers an additional view on the role of virus-mediated control of mRNA translation initiation and of the mechanisms that control MHC class I restricted antigen presentation in general.     

HSP70 mRNA translation in chicken reticulocytes is regulated at the level of elongation

During heat shock of chicken reticulocytes the synthesis of a single heat shock protein, HSP70, increases greater than 10-fold, while the level of HSP70 mRNA increases less than 2-fold during the same period. Comparison of the in vivo levels of HSP70 and beta-globin synthesis with their mRNA abundance reveals that the translation of HSP70 mRNA is repressed in normal reticulocytes and is activated upon heat shock. In its translationally repressed state HSP70 mRNA is functionally associated with polysomes based on sedimentation analysis of polysomes from untreated or puromycin-treated cells and by analysis of in vitro "run-off" translation products using isolated polysomes. Treatment of control and heat shocked cells with the initiation inhibitor pactamycin reveals that elongation of the HSP70 nascent peptide is not completely arrested, but is slower in control cells. Furthermore, the inefficient translation of HSP70 mRNA in vivo is not due to the lack of an essential translation factor; HSP70 mRNA is efficiently translated in chicken reticulocyte translation extracts as well as in heterologous rabbit reticulocyte extracts. Our results reveal that a major control point for HSP70 synthesis in reticulocytes is the elongation rate of the HSP70 nascent peptide.     

Control of phenylalanyl-tRNA synthetase genetic expression. Site-directed mutagenesis of the pheS, T operon regulatory region in vitro

Previous studies of phenylalanyl-tRNA synthetase expression in Escherichia coli strongly suggested that the pheS, T operon was regulated by a phenylalanine-mediated attenuation mechanism. To investigate the functions of the different segments composing the pheS, T attenuator site, a series of insertion, deletion and point mutations in the pheS, T leader region have been constructed in vitro on a recombinant M13 phage. The effects of these alterations on the regulation of the operon were measured after transferring each mutation onto a lambda phage carrying a pheS, T-lacZ fusion. The behaviours of the various mutants agree with the predictions of the attenuation model. The role of the antiterminator (2-3 pairing) as competitor of the terminator (3-4 pairing) is demonstrated by several mutations affecting the stability of the 2-3 base-pairing. The existence of deletions and point mutations in the 3-4 base-pairing shows that the terminator is essential for both expression level and regulation of the operon. Mutations in the translation initiation site of the leader peptide show that the expression of the leader peptide is essential for attenuation control. However, alteration of the translation initiation rate of the leader peptide derepresses the pheS, T operon, which is the opposite of what is observed with the trp operon. This difference is explained in terms of different translation initiation efficiencies of the leader peptides. Finally, insertion mutations, increasing gradually the distance between the leader peptide stop codon and the first strand of the antiterminator, derepress the pheS, T operon and show that formation of the antiterminator structure is under the control of the translation of the leader peptide.     

Comparative peptide binding studies of the PABC domains from the ubiquitin-protein isopeptide ligase HYD and poly(A)-binding protein. Implications for HYD function

The PABC domain is a peptide-binding domain that is specifically found in poly(A)-binding protein (PABP) and a HECT ubiquitin-protein isopeptide ligase (E3) known as HYD (hyperplastic discs), EDD (E3 isolated by differential display), or Rat100. The PABC domain of PABP recruits various regulatory proteins and translation factors to poly(A) mRNAs through binding of a conserved 12-amino acid peptide motif, PAM2 (PABP-interacting motif 2). In contrast, little is known about the specificity or function of the domain from HYD. Here, we used isothermal calorimetry and surface plasmon resonance titrations to show that the PABC domain of HYD binds PAM2 peptides with micromolar affinity. NMR chemical shift perturbations were used to map the peptide-binding site in the PABC domain of HYD. The structural features of binding are very similar to those of the interactions with the domain of PABP, which explains the overlapping peptide specificity and binding affinity. We identified the anti-proliferative Tob proteins as potential binding partners of HYD. This was confirmed by glutathione S-transferase pulldown and immunoprecipitation experiments demonstrating the interaction with full-length Tob2. Altogether, our results point to a role of the PABC domain as a protein-protein interaction domain that brings together the processes of translation, ubiquitin-mediated protein degradation, and cell cycle control.     

Regulated translation termination at the upstream open reading frame in s-adenosylmethionine decarboxylase mRNA.

The upstream open reading frame (uORF) in the mRNA encoding S-adenosylmethionine decarboxylase is a cis-acting element that confers feedback control by cellular polyamines on translation of this message. Recent studies demonstrated that elevated polyamines inhibit synthesis of the peptide encoded by the uORF by stabilizing a ribosome paused in the vicinity of the termination codon. These studies suggested that polyamines act at the termination step of uORF translation. In this paper, we demonstrate that elevated polyamines stabilize an intermediate in the termination process, the complete nascent peptide linked to the tRNA that decodes the final codon. The peptidyl-tRNA molecule is found associated with the ribosome fraction, and decay of this molecule correlated with release of the paused ribosome from the message. Furthermore, the stability of this complex is influenced by the same parameters that influence regulation by the uORF in vivo, namely the concentration of polyamines and the sequence of the uORF-encoded peptide. These results suggest that the regulated step in uORF translation is after formation of the peptidyl-tRNA molecule but before hydrolysis of the peptidyl-tRNA bond. This regulation may involve an interaction between the peptide, polyamines, and a target in the translational apparatus.